A Series of Briefs from the 2024 ECTRIMS Conference The European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) conference is the world’s largest gathering focused on advancements in…
Read More
Proposed Changes to How We Determine Who Has MS At the ECTRIMS meeting in September, there was a presentation on proposed updates to the 2017 McDonald criteria to diagnose MS….
New Medical Director on What’s Next in MS InforMS Magazine is excited to welcome the Rocky Mountain MS Center’s new Medical Director, Dr. Enrique Alvarez. While the title may be…
A new class of treatment approaches for MS being studied are Bruton’s Tyrosine Kinase (BTK) inhibitors, or BTKi. Designed as once-daily oral enzyme inhibitors, BTK inhibitors target specific immune cells…
Our immune system is a vast and powerful network, filled with specialized cells and proteins designed to protect us from infections and diseases. However, in autoimmune diseases like MS, some…
Research is the driver of progress in MS care and treatment. In this issue, we’ll take you inside some of the most promising innovations transforming the MS landscape. We begin…
The Rocky Mountain MS Center’s 2024 Fall Education Summit was held on Saturday, November 16, 2024, in-person at the Anschutz Medical Campus in Aurora, Colorado, and livestreaming on Zoom. Complete…
Conversations on MS with the Rocky Mountain MS Center Medical Director Dr. Enrique Alvarez, recorded live in Colorado Springs on October 29, 2024. ** PLEASE NOTE: We are aware of…
Open enrollment for healthcare insurance plans under the federal Affordable Care Act is underway beginning November 1. Open enrollment for Colorado marketplace health insurance runs from November 1st through December…
The Rocky Mountain MS Center team is heartbroken to share the loss of our close colleague and friend, Brooke Valdez. Brooke worked as a Program Manager for 12 years at…